ZOETIS, LLC | Zoetis | workplace safety or health violation | 2015 | OSHA | $7,140 |
ZOETIS, LLC | Zoetis | workplace safety or health violation | 2015 | OSHA | $14,700 |
ZOETIS LLC | Zoetis | environmental violation | 2019 | MI-ENV | $14,625 |
ZLB Behring, L.L.C. | CSL Limited | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Wyeth-Ayerst Laboratories Division | Pfizer | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
Wyeth Rouses Point | Pfizer | environmental violation | 2008 | EPA | $44,500 |
Wyeth Pharmaceuticals, Inc. | Pfizer | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
Wyeth Pharmaceuticals, Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Wyeth Pharmaceuticals Company, Inc. | Pfizer | environmental violation | 2010 | EPA | $77,000 |
WYETH PHARMACEUTICALS COMPANY - OTC | Pfizer | environmental violation | 2000 | EPA | $25,000 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Wyeth Biopharma | Pfizer | wage and hour violation | 2005 | WHD | $40,187 |
Wyeth Ayerst Pharmaceuticals | Pfizer | environmental violation | 2004 | EPA | $37,000 |
Wyeth | Pfizer | benefit plan administrator violation | 2013 | private lawsuit-federal | $2,000,000 |
Wyeth | Pfizer | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $2,100,000 |
WOCKHARDT USA MORTON GROVE DBA MORTON GROVE PHARMACEUTICALS, INC. | Wockhardt Limited | workplace safety or health violation | 2019 | OSHA | $7,900 |
Wockhardt USA | Wockhardt Limited | Medicare Coverage Gap Discount Program violation | 2020 | CMS | $111,824 |
Wockhardt Limited | Wockhardt Limited | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $340,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Watson, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | environmental violation | 2004 | EPA | $20,000 |
Watson Laboratories | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Warrick Pharmaceuticals Inc. | Merck | False Claims Act and related | 2009 | OH-AG | $4,300,000 |
Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $750,000 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | FDA | $430,000,000 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Warner Chilcott PLC | AbbVie | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
Warner Chilcott PLC | AbbVie | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,600,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2008 | private lawsuit-federal | $9,000,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Warner Chilcott Holdings | AbbVie | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Warner Chilcott | AbbVie | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $8,000,000 |
VISTAKON | Johnson & Johnson | environmental violation | 2005 | FL-DEP | $9,771 |
Valmed Pharmaceutical, Inc. | Teva Pharmaceutical Industries | wage and hour violation | 2004 | WHD | $83,871 |
Valeant Pharmaceuticals, Inc. | Bausch Health | insurance violation | 2018 | CA-INS | $1,875,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | benefit plan administrator violation | 2016 | EBSA | $10,001 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $37,500,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,750,000 |
United Therapeutics Corporation | United Therapeutics | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
ULTRAGENYX PHARMACEUTICAL | Ultragenyx Pharmaceutical | workplace safety or health violation | 2023 | OSHA | $12,054 |
UCB Pharma, Inc. | UCB | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
UCB Holdings, Inc. | UCB | benefit plan administrator violation | 2017 | private lawsuit-federal | $5,500,000 |
UCB Chemicals Corporation | UCB | price-fixing or anti-competitive practices | 2001 | private lawsuit-federal | $9,000,000 |
UCB CHEMICAL CORPORATION | UCB | environmental violation | 2001 | EPA | $6,824 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
Therasense, Inc. | Abbott Laboratories | labor relations violation | 2003 | NLRB | $236,827 |
TEVA SICOR | Teva Pharmaceutical Industries | workplace safety or health violation | 2005 | OSHA | $5,000 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | consumer protection violation | 2023 | KY-AG | $1,407,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | EPA | $61,158 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | $2,250,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | MO-AG | $70,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2006 | NJ-ENV | $6,200 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $15,300 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2016 | OSHA | $5,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | consumer protection violation | 2019 | CA-AG | $69,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
TEVA PHARMACEUTICAL | Teva Pharmaceutical Industries | workplace safety or health violation | 2000 | OSHA | $5,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |